Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
While the treatment mainstays for lowering and/or maintaining a target IOP are achieved with surgery, laser, or pharmaceuticals, patients often ask what else they can do. Several physicians spoke to EyeWorld about lifestyle changes that they recommend as an addition to traditional glaucoma therapies.
➤ Initial Phase 3 results for dry eye disease therapy ➤ Positive Phase 2 results for intravitreal implant for glaucoma and diabetic retinopathy ➤ Phase 1/2a results from allogenic cell therapy for geographic atrophy ➤ Phase 1 trial successful with oral treatment for non-proliferative diabetic retinopathy ➤ ASCRS news and events
➤ Preservative-free fixed-dose combination therapy for glaucoma in development ➤ Rare Pediatric Disease designation granted to investigational Stargardt gene therapy ➤ First patient dosed in genome editing program for corneal dystrophy ➤ ASCRS news and events
➤ FDA approves first-in-class DED drop ➤ FDA accepts NDA for topical presbyopia therapy ➤ TFOS DEWS III ➤ Topline results in Phase 3 study evaluating night driving impairment after keratorefractive surgery ➤ IND application submitted for pediatric myopia treatment ➤ Study sheds light on clinical inherited retinal diseases without genetic mutations ➤ ASCRS news and events
➤ Positive update from Phase 2 study evaluating oligonucleotide for AMD and DME ➤ 18-month data presented on novel drug delivery platform ➤ Phase 1/2a trial results for intravitreal injection for treatment of glaucoma ➤ Advancing AI to facilitate detection and improve management of ocular disease ➤ Fast Track designation granted for neuropathic corneal pain ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy ➤ ASCRS news and events
Steroid-induced glaucoma can present a number of issues, most notably increased IOP. Several ophthalmologists discussed identifying when and why this occurs and how to react to help improve the pressure.
Manjool Shah, MD, gave an overview of the articles in the Glaucoma section, noting, “The insights shared by our contributors serve as a reminder of the importance of continuous learning and adaptation, and there is no place better to feel the energy of lifelong learning like the ASCRS Annual Meeting.”
Pseudoexfoliation syndrome is a systemic, age-related disease, with patients needing more frequent monitoring due to an increased risk of developing secondary open angle glaucoma from the condition. Two physicians provided their perspectives on the condition and advice for its identification, management, and considerations for surgery.
Get the latest ophthalmology news delivered to your inbox every Friday.